Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.23 - $160.0 $12,069 - $8.4 Million
52,474 Added 2206.64%
54,852 $9,000
Q2 2022

Aug 10, 2022

SELL
$0.23 - $0.46 $8,366 - $16,732
-36,376 Reduced 93.86%
2,378 $1,000
Q1 2022

May 16, 2022

SELL
$0.3 - $0.61 $23,543 - $47,870
-78,477 Reduced 66.94%
38,754 $17,000
Q4 2021

Feb 14, 2022

BUY
$0.55 - $1.04 $64,477 - $121,920
117,231 New
117,231 $65,000
Q3 2021

Nov 15, 2021

SELL
$1.06 - $1.52 $24,723 - $35,452
-23,324 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$1.22 - $1.65 $32,674 - $44,190
-26,782 Reduced 53.45%
23,324 $35,000
Q1 2021

May 12, 2021

BUY
$1.18 - $2.62 $20,310 - $45,095
17,212 Added 52.33%
50,106 $77,000
Q4 2020

Feb 11, 2021

BUY
$1.05 - $2.24 $31,725 - $67,681
30,215 Added 1127.85%
32,894 $35,000
Q3 2020

Nov 12, 2020

SELL
$1.7 - $6.41 $22,043 - $83,118
-12,967 Reduced 82.88%
2,679 $5,000
Q2 2020

Jul 31, 2020

BUY
$0.87 - $2.46 $13,346 - $37,738
15,341 Added 5029.84%
15,646 $35,000
Q1 2020

May 01, 2020

SELL
$0.22 - $2.45 $21,596 - $240,506
-98,166 Reduced 99.69%
305 $0
Q4 2019

Feb 14, 2020

BUY
$0.11 - $0.58 $9,880 - $52,099
89,826 Added 1039.05%
98,471 $25,000
Q1 2019

May 14, 2019

SELL
$0.75 - $1.0 $3,459 - $4,612
-4,612 Reduced 34.79%
8,645 $8,000
Q4 2018

Feb 14, 2019

BUY
$0.57 - $1.05 $2,628 - $4,842
4,612 Added 53.35%
13,257 $10,000
Q3 2018

Nov 14, 2018

SELL
$0.64 - $0.91 $257 - $366
-403 Reduced 4.45%
8,645 $7,000
Q2 2018

Aug 14, 2018

BUY
$0.83 - $2.1 $7,509 - $19,000
9,048 New
9,048 $8,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.